ABIVAX SA: REMAINS ON TRACK TO SUBMIT FIRST NDA FOR OBEFAZIMOD FOR TREATMENT OF MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS BY END OF 2026

Reuters · 2d ago

Please log in to view news